Gene Therapy as a Treatment of Primary Immune Defects

3013

Sunday, March 6, 2016: 6:45 AM-7:45 AM

JW Marriott, Platinum Ballroom Level, Salon H

1.00 CME/CE

Seminar

Learning Objectives:

Discuss and analyze general information about gene therapy
Discuss current indications for gene therapy in patients with primary immunodeficiency
Evaluate considerations of future use of gene therapy in primary immunodeficiency disorders

Discussion Leader
Andrew M. Scharenberg, MD

Discussion Leader
Donald B. Kohn, MD

See more of: Session